Drugs / AdvVEGF-D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03039751 | Oct 2019 → Dec 2023 | Prinzmetal angina | Kuopio University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdvVEGF-D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03039751 ↗ |
| Route | Other | “AdvVEGF-D will be injected into 10 sites of the myocardium” NCT03039751 ↗ |